Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology

INTRODUCTION: A chemogenomic set of small molecules with annotated activities and implicated roles in Alzheimer's disease (AD) called the AD Informer Set was recently developed and made available to the AD research community: https://treatad.org/data‐tools/ad‐informer‐set/. METHODS: Small subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Potjewyd, Frances M., Annor‐Gyamfi, Joel K., Aubé, Jeffrey, Chu, Shaoyou, Conlon, Ivie L., Frankowski, Kevin J., Guduru, Shiva K. R., Hardy, Brian P., Hopkins, Megan D., Kinoshita, Chizuru, Kireev, Dmitri B., Mason, Emily R., Moerk, Charles T., Nwogbo, Felix, Pearce, Kenneth H., Richardson, Timothy I., Rogers, David A., Soni, Disha M., Stashko, Michael, Wang, Xiaodong, Wells, Carrow, Willson, Timothy M., Frye, Stephen V., Young, Jessica E., Axtman, Alison D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005681/
https://www.ncbi.nlm.nih.gov/pubmed/35434254
http://dx.doi.org/10.1002/trc2.12253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005681/
https://www.ncbi.nlm.nih.gov/pubmed/35434254
http://dx.doi.org/10.1002/trc2.12253

Ejemplares similares